Date | Time | Source | Headline | Symbol | Company |
08/05/2024 | 1:00PM | iHub Newswire | FeaturedNorth Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California | | |
12/18/2007 | 6:30AM | PR Newswire (US) | Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension | NYSE:FRX | Forest Road Acquisition Corp |
12/13/2007 | 4:20PM | PR Newswire (US) | Forest Laboratories Receives Notification of ANDA Filings for Generic Equivalents of Namenda(R) | NYSE:FRX | Forest Road Acquisition Corp |
12/13/2007 | 3:03PM | Edgar (US Regulatory) | Forest Laboratories Inc - Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
12/10/2007 | 4:45PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
12/10/2007 | 4:43PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
12/10/2007 | 4:42PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
12/10/2007 | 4:40PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
12/10/2007 | 4:38PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
12/10/2007 | 4:32PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
12/10/2007 | 4:30PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
12/10/2007 | 4:26PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
12/10/2007 | 4:24PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
12/10/2007 | 4:22PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
12/07/2007 | 12:42PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
12/02/2007 | 3:15PM | PR Newswire (US) | FDA Issues Approvable Letter for Nebivolol for the Treatment of Hypertension | NYSE:FRX | Forest Road Acquisition Corp |
11/29/2007 | 9:00AM | PR Newswire (US) | Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression | NYSE:FRX | Forest Road Acquisition Corp |
11/09/2007 | 4:05PM | Edgar (US Regulatory) | Forest Laboratories Inc - Quarterly Report (10-Q) | NYSE:FRX | Forest Road Acquisition Corp |
11/09/2007 | 4:05PM | Edgar (US Regulatory) | Forest Laboratories Inc - Quarterly Report (10-Q) | NYSE:FRX | Forest Road Acquisition Corp |
11/08/2007 | 8:30AM | PR Newswire (US) | Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show | NYSE:FRX | |
11/02/2007 | 2:10PM | PR Newswire (US) | Forest Laboratories and Cypress Bioscience to Host Webcast to Discuss Clinical Data Presentations for Milnacipran | NYSE:FRX | Forest Road Acquisition Corp |
11/01/2007 | 10:16AM | PR Newswire (US) | UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published i | NYSE:FRX | Forest Road Acquisition Corp |
11/01/2007 | 8:00AM | PR Newswire (US) | Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Jo | NYSE:FRX | Forest Road Acquisition Corp |
10/16/2007 | 8:05AM | PR Newswire (US) | Forest Laboratories Reports Earnings Per Share of $0.71 for Q2'08 Including $0.15 Charge Net of Tax for Licensing Charge | NYSE:FRX | Forest Road Acquisition Corp |
10/15/2007 | 4:10PM | PR Newswire (US) | Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia | NYSE:FRX | Forest Road Acquisition Corp |
10/12/2007 | 9:01AM | PR Newswire (US) | Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM) | NYSE:FRX | Forest Road Acquisition Corp |
10/08/2007 | 12:38PM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Second Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
09/18/2007 | 6:05AM | PR Newswire (US) | Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress | NYSE:FRX | Forest Road Acquisition Corp |
09/17/2007 | 8:03AM | PR Newswire (US) | Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration | NYSE:FRX | Forest Road Acquisition Corp |
09/05/2007 | 12:24PM | PR Newswire (US) | Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision | NYSE:FRX | Forest Road Acquisition Corp |